Press Releases

CHICAGO – NOVEMBER 30, 2015 – Samsung Electronics is strengthening its commitment to delivering fast, reliable, smart and innovative diagnostic solutions for healthcare providers by debuting the newest additions to its portfolio, on display at the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place in Chicago. This week at booth #7313 (North Building, Hall B), product specialists will be on hand demonstrating Samsung’s range of solutions in Computed Tomography (CT), Ultrasound and Digital Radiography (DR) systems, which are all designed to enrich the quality of care and workflow, and enhance the patient experience.

“Through our innovative designs and advanced technologies, we remain committed to delivering new solutions, like the NExCT 7 and the RS80A with Prestige, that unlock workflow efficiencies for medical professionals as well as improve patients’ lives,” said Soo-In Cho, President and Head of the Health & Medical Equipment Business at Samsung Electronics Co., Ltd. “By leveraging the combination of Samsung imaging technology and user-inspired design, we will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”

Computed Tomography (CT) Segment

Samsung’s CT imaging solutions are used throughout the world in intensive care units, neurosurgical operating rooms, emergency departments, stroke centers and other key clinical areas. Debuting at RSNA is:

• NExCT 7 – the first premium CT scanner from Samsung features high resolution designed to improve diagnostic confidence in advanced and routine exams reducing the radiation dose as low as reasonably achievable and ensuring a fast and efficient workflow. Some features of the NExCT7 are FDA 510(k) pending.
  
  
• Portable CT – Samsung will be showcasing the latest in software and hardware enhancements across its portable CT product line. These upgrades improve user satisfaction and streamline workflow, and both systems are now compliant with the Smart Dose (XR-29) radiation dose reporting standard.
  
  The BodyTom and CereTom portable systems continue to prove their versatility as they are increasingly adopted and utilized in a wide range of market applications such as mobile stroke units, brachytherapy suites, proton therapy centers, deep brain stimulation and even veterinarian hospitals.

Ultrasound Segment

Samsung continues to enhance the user experience with its cutting-edge diagnostic ultrasound devices around the world and across various medical fields. On display at RSNA are:

• RS80A with Prestige – now available in the U.S. market, this system features advanced technical capabilities built on the successes of Samsung technologies. Product features include:
  • S-Fusion to enable simultaneous localization of lesions with a real-time ultrasound image supported by other modalities' 3D data sets. Fusion speed and accuracy are the strengths of S-Fusion.
  • S-Shearwave to detect the velocity of the shearwave transmitted through the targeted lesion and display the numerical measurement of stiffness.
  • E-Breast*: this is the function for breast lesion exam, which calculates the strain between the area of the suspected lesion (ROI) and normal breast fat and displays the results.
  • E-Thyroid*: This function assists with the diagnosis of thyroid lesions. The ROI is used to show the contrast of an elastogram.
    *The strain ratio value is a relative value regarding quantification, not an absolute value.
    
    
• HS70A – designed for hospital and private care. This system has a flexible architecture to meet the clinical needs of varied users. The HS70A offers a complete Radiology and Cardiovascular solution, including technologies migrated from the premium radiology RS80A platform. Features include S-Detect, which uses Breast Imaging-Reporting, and Data System (BI-RADS®) scores for analysis and classification of suspicious lesions.

Digital Radiography (DR) Segment 

Samsung’s DR systems combine advanced imaging technology, award-winning design and user-friendly automated workflows to meet the demands of 21st century radiology departments. Products on display at RSNA include:

• GC85A – a DR system offering streamlined workflow, diagnostic confidence and improved total cost of ownership. The GC85A features imaging engine S-Vue, ensuring consistency with high quality, convenient setting of contrast and improved sharpness and clarity, S-Share to support unique clinical needs and continuous care with increased connectivity, and Smart Control for one-touch precise positioning.

• GM60A – a mobile Digital Radiography system that delivers high-quality imaging directly to the patient’s bedside. Advanced mobility allows use in the patient room, emergency room, operating room and the intensive care unit, and has advanced features, including S-Detector and S-Vue imaging technologies to deliver accurate diagnoses while ensuring reliable operation with enhanced usability. Additionally, the telescopic column ensures fast navigation by securing a clear view for users.

For more information about Samsung’s showcase at RSNA, please visit http://www.samsung.com/rsna2015.  To learn more about Samsung’s healthcare work, please visit samsung.com/global/business/healthcare/.

To read this press release on Business Wire, please click here.

About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. inspires the world and shapes the future with transformative ideas and technologies that redefine the worlds of TVs, smartphones, wearable devices, tablets, cameras, digital appliances, printers, medical equipment, network systems, and semiconductor and LED solutions. We are also leading in the Internet of Things space with the open platform SmartThings, our broad range of smart devices, and through proactive cross-industry collaboration. We employ 319,000 people across 84 countries with annual sales of US $196 billion. To discover more, and for the latest news, feature articles and press material, please visit the Samsung Newsroom at news.samsung.com.

About NeuroLogica
NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.

DANVERS, MA - Samsung is pleased to announce that its full line of computed tomography systems, including BodyTom^® and CereTom^®, are compliant with Medical Imaging & Technology Alliance (MITA) Smart Dose (XR-29) radiation dose reporting standards.  All new systems sold are 100% compliant, and any installed system can easily be upgraded to include these new features. National Electrical Manufacturers Association (NEMA) XR-29, also known as the MITA Smart Dose Standard, is a quality initiative to promote patient safety and public health in CT diagnostic imaging. Samsung is dedicated to customer centric innovation and providing the industry with the tools and resources they need to keep patients and clinicians safe.

NEMA Standard XR-29 identifies common CT system attributes that contribute to or help perform dose optimization/management of ionizing radiation while still enabling the system to deliver the diagnostic image quality needed by the physician. These attributes include DICOM radiation dose structured reporting, pediatric and adult reference protocols, CT dose check, and automatic exposure control. The intent of this new standard is to ensure patient safety and provider compliance that elevates the quality of care.

“Samsung fully supports the MITA Smart Dose Standard and ensuring that our CT systems meet this critical new industry standard was an important objective that we are pleased to have achieved. We understand the need to deliver high diagnostic image quality at the lowest dose required. Samsung prides itself on designing solutions for radiation dose management, always with patient safety in mind” said Philip Sullivan, Samsung, NeuroLogica Division, President & CEO.

Samsung will showcase its dose management solutions in booth #7313 at the Radiological Society of North America Annual Meeting (RSNA), November 29^th through December 4^th in Chicago, IL. Visit www.samsung.com/RSNA2015 and follow @SamsungHealthUS for more information on Samsung’s presence at #RSNA2015.

About NeuroLogica
NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please see visit, www.SamsungNeuroLogica.com

About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. inspires the world and shapes the future with transformative ideas and technologies, redefining the worlds of TVs, smartphones, wearable devices, tablets, cameras, digital appliances, printers, medical equipment, network systems, and semiconductor and LED solutions. We are also leading in the Internet of Things space through, among others, our Smart Home and Digital Health initiatives. We employ 307,000 people across 84 countries with annual sales of US $196 billion. To discover more, please visit our official website at www.samsung.com and our official blog at global.samsungtomorrow.com.

CONTACTS:
Lynne Gagne
978-564-8576
lgagne@samsungneurologica.com

BOSTON--( BUSINESS WIRE)--More than 7,500 emergency physicians will see the CereTom® CT (computed tomography) mobile stroke unit (MSU) in action at this year’s American College of Emergency Physicians (ACEP) Scientific Assembly taking place in Boston from October 26 - 29. The MSU on display at ACEP15 was co-developed by Stryker, Frazer and Samsung NeuroLogica.

A trending topic at this year’s ACEP meeting, stroke continues to be a leading cause of death in the United States. A mobile stroke unit (MSU) is a specialized emergency medical vehicle that can help diagnose stroke in patients, as well as identify ischemic vs. hemorrhagic strokes. The CereTom CT scanner is a critical element of the process. For many stroke patients, time is critical for administering treatment that can prevent or minimize brain injury, and MSU teams can act on diagnostic tests right there in the vehicle. Last year the University of Texas Health Science Center at Houston (UTHealth) Medical School debuted the nation’s first MSU, in partnership with Memorial Hermann-Texas Medical Center. There are currently four active mobile stroke unit programs in the US, and interest is growing from both academic and non-academic medical centers.

To read the full article, please click here.

DANVERS, Mass.--( BUSINESS WIRE)-- Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. and a leading provider of advanced imaging solutions, announced today that the University of Wisconsin (UW) Carbone Cancer Center in Madison acquired and is incorporating NeuroLogica’s BodyTom® technology into its radiation oncology brachytherapy planning process. UW Carbone Cancer Center is the first center in the world to use the BodyTom scanner for brachytherapy treatment.

The BodyTom CT further distinguishes UW Carbone Cancer Center, the state’s only National Cancer Institute-certified comprehensive cancer center  that recently landed 15 physicians on Newsweek’s “Top Cancer Doctors 2015” list. The 32-slice portable CT scanner will be stationed in the brachytherapy suite, enabling patients to undergo radiation imaging, planning and treatment in a single location.

"Having in-room, high-quality CT imaging removes the need for patient transfer while under anesthesia during the procedure to a separate CT suite, and provides opportunities for pre- and post-implant quality assessment," said Greg Cooley, M.D., "and we can use the BodyTom CT in both of our suites without duplication of equipment for each room."

To read the full article, please click here.

DANVERS, Mass.--( BUSINESS WIRE)--Samsung has been awarded a group purchasing agreement for General Radiography, Computed Tomography, & Ultrasound with Premier, Inc., a leading healthcare improvement company, effective October 1, 2015. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Digital Radiography, CT, & Ultrasound products.

“Samsung is extremely pleased to form this new relationship with Premier, a world-class organization and recognized leader in healthcare improvement. Samsung is making critical investment to help healthcare providers enhance patient care, improve patient satisfaction and increase workflow efficiency with our entire healthcare portfolio. We understand the need to improve healthcare outcomes while lowering costs. We are excited to be a partner with Premier in transforming the provider and patient experience” said Phil Sullivan, Samsung, NeuroLogica Division, President & CEO.

Samsung’s full range of imaging solutions are designed to enhance the quality of care and transform the patient experience. The product portfolio includes Digital Radiography (DR), Ultrasound and portable Computed Tomography (CT) systems. Samsung is committed to delivering fast, easy and accurate diagnostic solutions for healthcare providers and continually demonstrates to the healthcare community how the combination of Samsung imaging technology, user-inspired design and customer-centric innovation can help enhance the quality of care for patients and unlock workflow efficiencies for hospitals and providers.

About NeuroLogica
NeuroLogica, the healthcare subsidiary of Samsung Electronics America Inc., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please see visit, www.SamsungNeuroLogica.com.

About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. inspires the world and shapes the future with transformative ideas and technologies, redefining the worlds of TVs, smartphones, wearable devices, tablets, cameras, digital appliances, printers, medical equipment, network systems, and semiconductor and LED solutions. We are also leading in the Internet of Things space through, among others, our Smart Home and Digital Health initiatives. We employ 307,000 people across 84 countries with annual sales of US $196 billion. To discover more, please visit our official website at www.samsung.com and our official blog at global.samsungtomorrow.com.

 

The Samsung GC85A offers streamlined workflows, diagnostic confidence, and improved total cost of ownership.

Danvers, MA –  August 6, 2015 – NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd, announced that the Samsung GC85A Digital Radiography (DR) system has received 510(k) FDA clearance, paving the way for its availability in the US market. The GC85A is the latest expansion of Samsung’s growing DR portfolio, which also includes the mobile digital GM60A, the U-arm digital GU60A, and the ceiling digital GC80.

Samsung’s DR systems combine advanced imaging technology, award-winning design and user-friendly automated workflows to meet the demands of 21st century radiology departments. The Samsung GC85A is a ceiling digital X-ray system that offers streamlined workflows, diagnostic confidence and improved total cost of ownership. Key features include:

• S-Vue imaging engine – provides dependable and accurate diagnoses in various conditions with reliably clear images, enhanced sharpness and clarity, and adjustable contrast presets.
• Wireless, lightweight S-Detector with high DQE and a portable grid – displays the patient’s body structure clearly and easily without increasing dose.
• Smart Control – enables the operator to precisely position the entire system with one touch of the control panel’s buttons. The user can move a motorized, tilting receptor with a remote control from -20 to 90 degrees to various areas such as skulls or hands with no need for a table.
• S-Align –provides precise alignment for exceptional imaging. S-Align displays the detector’s angle to the THU to enhance image quality during free exams. When the THU and detector are within a certain radius, the angle can be automatically fitted.
• Smart Stitching – eliminates the need for the patient to stand for long periods of consecutive shooting. Plus, a stitched image supports diagnostic clarity more than separated images.
• S-Share Compatibility – S-Detectors are compatible with Samsung DR Systems, so when a detector is discharged, it can be used with detectors from other compatible Samsung DR equipment. Various detector configurations support unique clinical needs and continuous care.

“The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user- and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses, ” said David Webster, Vice President of Global Sales & Chief Marketing Officer at NeuroLogica. “The system’s superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation.”

 

KALAMAZOO, MI and DANVERS, MA – January 6, 2014 – Stryker Corporation and NeuroLogica, a subsidiary of Samsung Electronics America Inc., announced an exclusive partnership agreement in which Stryker will promote and sell NeuroLogica’s BodyTom portable full body computed tomography (CT) scanner for the specialties of neurosurgery